Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
Wednesday, January 04, 2023Gilead Sciences Inc and EVOQ Therapeutics Inc EVOQ today announced a collaboration and licensing agreement to advance EVOQs proprietary technology for the treatment of rheumatoid arthritis RA and lupus EVOQs NanoDisc technology is designed to enable...
AmerisourceBergen completes acquisition of PharmaLex
Wednesday, January 04, 2023AmerisourceBergen Corporation today announced the completion of its acquisition of PharmaLex Holding GmbH The acquisition of PharmaLex enhances AmerisourceBergens growth strategy by advancing its leadership in specialty services and global platform o...
Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China
Thursday, December 29, 2022Mission Bio the pioneer in highthroughput singlecell DNA and multiomics analysis and Abiosciences the singlecell bioinformatics leader announced a new partnership to codevelop bioinformatics packages for translational and clinical research applicatio...
Opus Genetics Announces Acquisition of the Rights to Two Gene Therapy Product Candidates for Inherited Retinal Diseases
Thursday, December 29, 2022Opus Genetics a patientfirst clinicalstage gene therapy company developing treatments for inherited retinal diseases today announced it has acquired the rights to two preclinicalstage AAVbased gene therapy product candidates for inherited retinal dis...
Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED
Wednesday, December 28, 2022Kala Pharmaceuticals Inc a clinicalstage biopharmaceutical company dedicated to the research development and commercialization of innovative therapies for rare diseases of the eye today announced that the US Food and Drug Administration FDA has accep...
Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics
Wednesday, December 28, 2022Gilead Sciences Inc and Jounce Therapeutics Inc amended their existing license agreement for GS formerly JTX enabling Gilead to buy out remaining contingent payments potentially due under the license agreement executed in August As part of the trans...
Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region
Tuesday, December 27, 2022Hikma Pharmaceuticals PLC Hikma the multinational pharmaceutical company today announces a new exclusive licensing and commercialization agreement with Junshi Biosciences an innovationdriven biopharmaceutical company for toripalimab in the Middle Eas...
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies
Tuesday, December 27, 2022Ablaze Pharmaceuticals announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co Ltd Yonghe to develop series of targeted radiopharmaceutical therapy TRT products Under the agreement Yongh...
Lilly and ProQR to Expand RNA Editing Collaboration
Friday, December 23, 2022Eli Lilly and Company and ProQR Therapeutics NV today announced the expansion of their licensing and collaboration agreement focused on the discovery development and commercialization of new genetic medicines The collaboration originally announced in...
Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates
Friday, December 23, 2022Merck a leading science and technology company today announced a research collaboration and commercial license agreement with Mersana Therapeutics Inc Cambridge Massachusetts USA to discover novel antibodydrug conjugates ADCs leveraging Mersanas prop...
